Evidence map›Paper›PMID 31829939›Full record

ArticleeLife2019

Essential role for InSyn1 in dystroglycan complex integrity and cognitive behaviors in mice.

Akiyoshi Uezu, Erin Hisey, Yoshihiko Kobayashi, Yudong Gao, Tyler Wa Bradshaw, Patrick Devlin, Ramona Rodriguiz, Purushothama Rao Tata, Scott Soderling

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. SUMOylation targeting mitophagy in cardiovascular diseases.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Akiyoshi UezuDepartment of Cell Biology, Duke University Medical School, Durham, United States.ORCID 0000-0001-8478-4460
Erin HiseyDepartment of Cell Biology, Duke University Medical School, Durham, United States.
Yoshihiko KobayashiDepartment of Cell Biology, Duke University Medical School, Durham, United States.ORCID 0000-0001-7031-1478
Yudong GaoDepartment of Cell Biology, Duke University Medical School, Durham, United States.
Tyler Wa BradshawDepartment of Cell Biology, Duke University Medical School, Durham, United States.
Patrick DevlinDepartment of Cell Biology, Duke University Medical School, Durham, United States.ORCID 0000-0002-0359-4620
Ramona RodriguizDepartment of Psychiatry and Behavioral Sciences, Duke University Medical School, Durham, United States.
Purushothama Rao TataDepartment of Cell Biology, Duke University Medical School, Durham, United States.ORCID 0000-0003-4837-0337
Scott SoderlingDepartment of Cell Biology, Duke University Medical School, Durham, United States.ORCID 0000-0001-7808-197X
Duke University · US

Funding

Analysis of Inhibitory Synaptic Proteins Associated with Brain DisordersR01NS102456 · NINDS · DUKE UNIVERSITY · PI SODERLING, SCOTT H · 2017 to 2021
$2.6M
To define the role of SOX9 and Sox9+ cells in alveolar homeostasis and regenerationR00HL127181 · NHLBI · DUKE UNIVERSITY · PI TATA, PURUSHOTHAMA RAO · 2017 to 2019
$738k
To define the role of SOX9 and Sox9+ cells in alveolar homeostasis and regenerationK99HL127181 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TATA, PURUSHOTHAMA RAO · 2015 to 2016
$273k
NHLBI NIH HHS HL127181NHLBI NIH HHS K99 HL127181NHLBI NIH HHS R00 HL127181NINDS NIH HHS NS102456NINDS NIH HHS R01 NS102456
6 · The paper itself

Abstract

Human mutations in the dystroglycan complex (DGC) result in not only muscular dystrophy but also cognitive impairments. However, the molecular architecture critical for the synaptic organization of the DGC in neurons remains elusive. Here, we report Inhibitory Synaptic protein 1 (InSyn1) is a critical component of the DGC whose loss alters the composition of the GABAergic synapses, excitatory/inhibitory balance in vitro and in vivo, and cognitive behavior. Association of InSyn1 with DGC subunits is required for InSyn1 synaptic localization. InSyn1 null neurons also show a significant reduction in DGC and GABA receptor distribution as well as abnormal neuronal network activity. Moreover, InSyn1 null mice exhibit elevated neuronal firing patterns in the hippocampus and deficits in fear conditioning memory. Our results support the dysregulation of the DGC at inhibitory synapses and altered neuronal network activity and specific cognitive tasks via loss of a novel component, InSyn1.

Indexed as

MemoryAnimalsCells, CulturedCognitionDystroglycansGABAergic NeuronsHippocampusHumansMice, Inbred C57BLSynapsesSynapsinsDystroglycansSYN1 protein, humanSynapsinsdystrophin/dystroglycan complexGABAhippocampusinhibitory synapseInSyn1memorymouseneuroscience

Identifiers

PMID31829939
PMCPMC6944460
OpenAlexW2995678852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.